Research work · 2020
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial
Jeff Porter Sharman, Miklós Egyed, Wojciech J. Jurczak, Alan Pierre Zausner Skarbnik, John M. Pagel, Ian W. Flinn, Manali Kirtikumar Kamdar, Talha Munir, Renata J. Walewska, Gillian Corbett, Laura Fogliatto, Yair Herishanu, Versha Banerji, Steven E. Coutre, George Follows, Patricia Walker, Karin Karlsson, Paolo Ghia, Ann M. Janssens, Florence Cymbalista
The Lancet